Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-28
DOI
10.1038/s41386-020-00948-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PET imaging shows no changes in TSPO brain density after IFN-α immune challenge in healthy human volunteers
- (2020) M. A. Nettis et al. Translational Psychiatry
- Inflammation in mild cognitive impairment due to Parkinson's disease, Lewy body disease, and Alzheimer's disease
- (2019) Eleanor King et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Cytokine Research in Depression: Principles, Challenges, and Open Questions
- (2019) Hubertus Himmerich et al. Frontiers in Psychiatry
- Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue
- (2019) Daniela Enache et al. BRAIN BEHAVIOR AND IMMUNITY
- Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels
- (2019) Emanuele Felice Osimo et al. PSYCHOLOGICAL MEDICINE
- Novel Neuroimmunologic Therapeutics in Depression: A Clinical Perspective on What We Know So Far
- (2019) Michael Roman et al. BRAIN BEHAVIOR AND IMMUNITY
- Minocycline inhibits microglial activation and alleviates depressive-like behaviors in male adolescent mice subjected to maternal separation
- (2019) Yue Han et al. PSYCHONEUROENDOCRINOLOGY
- Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials
- (2018) Joshua D. Rosenblat et al. JOURNAL OF AFFECTIVE DISORDERS
- Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial
- (2018) Jonathan B. Savitz et al. Translational Psychiatry
- Pharmacological Inhibition of Indoleamine 2,3-Dioxygenase-2 and Kynurenine 3-Monooxygenase, Enzymes of the Kynurenine Pathway, Significantly Diminishes Neuropathic Pain in a Rat Model
- (2018) Ewelina Rojewska et al. Frontiers in Pharmacology
- Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome
- (2018) Alice Russell et al. PSYCHONEUROENDOCRINOLOGY
- Minocycline as an adjunct for treatment-resistant depressive symptoms: A pilot randomised placebo-controlled trial
- (2017) Muhammad I Husain et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome
- (2017) D D Kiraly et al. Translational Psychiatry
- Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults
- (2016) Glenda MacQueen et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
- (2016) Sidney H. Kennedy et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
- (2016) Ole Kohler et al. Current Neuropharmacology
- Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients
- (2016) Hamid Emadi-Kouchak et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- A protocol for the Hamilton Rating Scale for Depression: Item scoring rules, Rater training, and outcome accuracy with data on its application in a clinical trial
- (2016) Kelly J. Rohan et al. JOURNAL OF AFFECTIVE DISORDERS
- Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression
- (2016) E Haroon et al. MOLECULAR PSYCHIATRY
- Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation
- (2016) Andrew H Miller et al. NEUROPSYCHOPHARMACOLOGY
- Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study
- (2015) Ju-Young Shin et al. BMJ-British Medical Journal
- Risk of intracranial haemorrhage in antidepressant users with concurrent use of non-steroidal anti-inflammatory drugs: nationwide propensity score matched study
- (2015) Ju-Young Shin et al. BMJ-British Medical Journal
- Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects
- (2014) Ole Köhler et al. JAMA Psychiatry
- A tutorial on sensitivity analyses in clinical trials: the what, why, when and how
- (2013) Lehana Thabane et al. BMC Medical Research Methodology
- Infections in Children and Adolescents With Juvenile Idiopathic Arthritis and Inflammatory Bowel Disease Treated With Tumor Necrosis Factor- Inhibitors: Systematic Review of the Literature
- (2013) S. S. Toussi et al. CLINICAL INFECTIOUS DISEASES
- Novel therapeutic targets in depression: Minocycline as a candidate treatment
- (2012) Joanna K. Soczynska et al. BEHAVIOURAL BRAIN RESEARCH
- Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: Randomized double-blind placebo-controlled study
- (2012) Seyed-Hesameddin Abbasi et al. JOURNAL OF AFFECTIVE DISORDERS
- Minocycline as adjunctive therapy for patients with unipolar psychotic depression: An open-label study
- (2012) Tsuyoshi Miyaoka et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Childhood maltreatment is associated with increased body mass index and increased C-reactive protein levels in first-episode psychosis patients
- (2012) N. Hepgul et al. PSYCHOLOGICAL MEDICINE
- A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
- (2012) Charles L. Raison et al. JAMA Psychiatry
- Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction
- (2011) Anne-Marie Schjerning Olsen et al. CIRCULATION
- Multiplex measurement of proinflammatory cytokines in human serum: Comparison of the Meso Scale Discovery electrochemiluminescence assay and the Cytometric Bead Array
- (2011) Djeneba Dabitao et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans
- (2011) J. L. Warner-Schmidt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Psychometric evaluation of the Snaith–Hamilton pleasure scale in adult outpatients with major depressive disorder
- (2010) Paul A. Nakonezny et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Antidepressant Drug Effects and Depression Severity
- (2010) Jay C. Fournier et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disorders
- (2010) Gregory F. Oxenkrug JOURNAL OF NEURAL TRANSMISSION
- Comparison of Depressive Symptom Severity Scores in Low-Income Women
- (2010) Shawn M. Kneipp et al. NURSING RESEARCH
- A Novel Target of Action of Minocycline in NGF-Induced Neurite Outgrowth in PC12 Cells: Translation Initiation Factor eIF4AI
- (2010) Kenji Hashimoto et al. PLoS One
- Does minocycline have antidepressant effect?
- (2008) Chi-Un Pae et al. BIOMEDICINE & PHARMACOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started